Reneo Pharmaceuticals (RPHM) Revenue & Revenue Breakdown
Reneo Pharmaceuticals Revenue Highlights
Reneo Pharmaceuticals Revenue by Period
Reneo Pharmaceuticals Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2023-12-31 | - | 100.00% |
| 2022-12-31 | - | 100.00% |
| 2021-12-31 | - | 100.00% |
| 2020-12-31 | - | 100.00% |
| 2019-12-31 | - | - |
Reneo Pharmaceuticals generated - in revenue during NA 2023, up 100.00% compared to the previous quarter, and up 0.00% compared to the same period a year ago.
Reneo Pharmaceuticals Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2024-06-30 | - | 100.00% |
| 2024-03-31 | - | -100.00% |
| 2023-12-31 | $734.00K | 100.00% |
| 2023-09-30 | - | 100.00% |
| 2023-06-30 | - | 100.00% |
| 2023-03-31 | - | 100.00% |
| 2022-12-31 | - | 100.00% |
| 2022-09-30 | - | 100.00% |
| 2022-06-30 | - | 100.00% |
| 2022-03-31 | - | 100.00% |
| 2021-12-31 | - | 100.00% |
| 2021-09-30 | - | 100.00% |
| 2021-06-30 | - | 100.00% |
| 2021-03-31 | - | 100.00% |
| 2020-12-31 | - | 100.00% |
| 2020-09-30 | - | 100.00% |
| 2020-06-30 | - | 100.00% |
| 2020-03-31 | - | - |
Reneo Pharmaceuticals generated - in revenue during Q2 2024, up 100.00% compared to the previous quarter, and up NaN% compared to the same period a year ago.
Reneo Pharmaceuticals Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| RPRX | Royalty Pharma | $2.35B | $567.98M |
| APLS | Apellis Pharmaceuticals | $366.28M | $179.14M |
| LEGN | Legend Biotech | $285.14M | $93.99M |
| DNA | Ginkgo Bioworks | $251.46M | $56.21M |
| ADPT | Adaptive Bio | $170.28M | $43.19M |
| VIR | Vir Bio | $86.18M | $3.08M |
| HOWL | Werewolf Therapeutics | $19.94M | $742.00K |
| KZR | Kezar Life Sciences | $7.00M | - |
| KRON | Kronos Bio | $6.29M | $2.69M |
| CGEM | Cullinan Oncology | - | - |
| CCCC | C4 Therapeutics | - | - |
| AVRO | AVROBIO | - | - |
| CNSP | CNS Pharmaceuticals | - | - |
| NKTX | Nkarta | - | - |
| PRME | Prime Medicine | - | - |
| DBTX | Decibel Therapeutics | - | - |
| SMMT | Summit Therapeutics | - | - |
| CELC | Celcuity | - | - |
| OCEA | Ocean Biomedical | - | - |
| IMMX | Immix Biopharma | - | - |
| EWTX | Edgewise Therapeutics | - | - |
| HEPA | Hepion Pharmaceuticals | - | - |
| RPHM | Reneo Pharmaceuticals | - | - |
RPHM Revenue FAQ
What is Reneo Pharmaceuticals’s yearly revenue?
Reneo Pharmaceuticals's yearly revenue for 2023 was $0, representing an increase of 100.00% compared to 2022. The company's yearly revenue for 2022 was $0, representing an increase of 100.00% compared to 2021. RPHM's yearly revenue for 2021 was $0, representing an increase of 100.00% compared to 2020.
What is Reneo Pharmaceuticals’s quarterly revenue?
Reneo Pharmaceuticals's quarterly revenue for Q2 2024 was $0, a 100.00% increase from the previous quarter (Q1 2024), and a 0% increase year-over-year (Q2 2023). The company's quarterly revenue for Q1 2024 was $0, a -100.00% decrease from the previous quarter (Q4 2023), and a 0% increase year-over-year (Q1 2023). RPHM's quarterly revenue for Q4 2023 was $734K, a 100.00% increase from the previous quarter (Q3 2023), and a 0% increase year-over-year (Q4 2022).
What is Reneo Pharmaceuticals’s revenue growth rate?
Reneo Pharmaceuticals's revenue growth rate for the last 3 years (2021-2023) was 0%, and for the last 5 years (2019-2023) was 0%.